Breast Cancer Research and Treatment

Breast Cancer Res Treat · ISSN (print) 0167-6806 · ISSN (e) 1573-7217 · 19 papers in corpus
review 2025
doi:10.1007/s10549-024-07522-4 ·PMID:39531132

Despite progress, breast cancer remains the most feared disease among women. In the USA alone, the incidence is now almost 300,000 new cancers per year, a rate that has nearly doubled in the last 30 years. Most women survive, but over 40,00…

observational 2025
doi:10.1007/s10549-025-07689-4 ·PMID:40159249

PURPOSE: Circulating levels of sex steroid hormones have previously been associated with premenopausal breast cancer risk. Few studies have considered the association between dietary patterns and premenopausal hormone levels. Our objective …

diagnostic-accuracy 2025
doi:10.1007/s10549-025-07672-z ·PMID:40148706

PURPOSE: This study aims to test the hypothesis that an enzyme-linked antibody-lectin sandwich assay for a glycovariant of CA15-3 can deliver better diagnostic performance, defined by classification accuracy, sensitivity and specificity, fo…

observational 2024
doi:10.1007/s10549-024-07257-2 ·PMID:38459395

PURPOSE: Although infertility (i.e., failure to conceive after ≥ 12 months of trying) is strongly correlated with established breast cancer risk factors (e.g., nulliparity, number of pregnancies, and age at first pregnancy), its association…

observational 2023
doi:10.1007/s10549-022-06789-9 ·PMID:36331687

PURPOSE: Preeclampsia has been inconsistently associated with altered later life risk of cancer. This study utilizes the Nurses' Health Study 2 (NHS2) to determine if the future risk of breast and non-breast cancers in women who experience …

observational 2023
doi:10.1007/s10549-023-06907-1 ·PMID:36928623

PURPOSE: Research on infertility and risk of breast cancer has been conflicting, potentially because many well-established breast cancer risk factors, such as pregnancy history, are strongly correlated with infertility. METHODS: We followe…

observational 2023
doi:10.1007/s10549-023-07211-8 ·PMID:38141056

PURPOSE: Given the relatively high incidence of both endometriosis and breast cancer, investigating the potential connection between these gynecological diseases is of substantial clinical significance. However, there is no clear consensus …

rct 2023
doi:10.1007/s10549-023-06985-1 ·PMID:37336835

BACKGROUND: Breast Cancer incidence in the UK is estimated to rise to 71,000 per year by 2035. Preventative strategies could significantly reduce this. Preventative therapy reduces women's risk of oestrogen receptor positive breast cancer, …

lab-animal 2021
doi:10.1007/s10549-020-05948-0 ·PMID:33001337

PURPOSE: Triple negative breast cancer (TNBC), an aggressive subtype of breast cancer, lacks the three major receptors for predicting outcome or targeting therapy. Hence, our aim was to evaluate the potential of estrogen receptor beta (ERβ)…

observational 2021
doi:10.1007/s10549-020-05951-5 ·PMID:33047206

PURPOSE: While chemotherapy has improved survival among younger women with breast cancer, it can induce temporary or permanent chemotherapy-related amenorrhoea (CRA), impacting survival benefit, quality of life and, importantly for younger …

observational 2016
doi:10.1007/s10549-016-3957-y ·PMID:27604359

PURPOSE: Given the altered hormonal and inflammatory environment of women with endometriosis, several studies have suggested a positive association between endometriosis and breast cancer, although findings have been mixed. This study inves…

observational 2014
doi:10.1007/s10549-014-2885-y ·PMID:24584822

Late effects of breast cancer affect the quality of survivorship. Using administrative data, we compared the occurrence of almost all ICD9 codes among older breast cancer survivors to that among a matched comparison cohort to generate new h…

observational 2013
doi:10.1007/s10549-013-2592-0 ·PMID:23764995

Prolonged exposure to combined hormone replacement therapy (estrogen plus progestin) increases a woman's risk of breast cancer, whereas estrogen-only hormone replacement therapy does not. This suggests that progesterone may play a role in b…

other 2013
doi:10.1007/s10549-012-2335-7 ·PMID:23242613

Although pain is common among post-treatment breast cancer survivors, studies that are longitudinal, identify a case definition of clinically meaningful pain, or examine factors contributing to pain in survivors are limited. This study desc…

observational 2012
doi:10.1007/s10549-011-1834-2 ·PMID:22037829

There is evidence that aspirin use reduces the risk of breast cancer. Increased mammographic density is known to be associated with increased breast cancer risk. Little is known about the association between mammographic density and aspirin…

lab-animal 2011
doi:10.1007/s10549-010-0957-1 ·PMID:20514515

The cell surface receptor tissue factor (TF) is regarded as a common but specific target on angiogenic tumor vascular endothelial cells (VECs) and tumor cells in many types of cancer including breast cancer. The purpose of this study is to …

lab-animal 1988
doi:10.1007/BF01805741 ·PMID:2973820

Based on our previous findings that medroxyprogesterone acetate (MPA) significantly suppressed the formation of preneoplastic mammary hyperplastic alveolar nodules in mice, and that this suppression persisted for some time, we studied the e…

case-report 1984
doi:10.1007/bf01806989 ·PMID:6697011
observational 1983
doi:10.1007/bf01806233 ·PMID:6871481

The uncomplicated non-encapsulated sclerosing lesion (NESL) or radial scar of breast is a banal lesion which may be confused with tubular carcinoma. Yet, that the latter may arise in such scars is strongly suggested by the recognition of ex…